DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cialis (Tadalafil) - Summary

 

-- advertisement --

CIALIS SUMMARY

CIALIS®
(tadalafil)
tablets

CIALIS® (tadalafil), an oral treatment for erectile dysfunction, is a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5).

CIALIS is indicated for the treatment of erectile dysfunction.

CIALIS NEWS HIGHLIGHTS

Media Articles Related to Cialis (Tadalafil)

Declaration Opposes Transplant Commercialism, Transplant Tourism, And Organ Trafficking
Source: Transplants / Organ Donations News From Medical News Today [2008.08.14]

Jhpiego Malaria Specialist Receives African Public Health Award
Source: Tropical Diseases News From Medical News Today [2008.07.22]

Headache Specialists Convene In Boston For 50th Annual American Headache Society Meeting
Source: Headache / Migraine News From Medical News Today [2008.06.27]

Cialis Eases Erectile Dysfunction After Spinal Cord Injury
Source: MedicineNet tadalafil Specialty [2007.09.14]

Naked Scientist Wins Royal Society Award For Science Communication
Source: IT / Internet / E-mail News From Medical News Today [2008.08.28]

more>>

Published Studies Related to Cialis (Tadalafil)

Investigating women's preference for sildenafil or tadalafil use by their partners with erectile dysfunction: the partners' preference study. [2008.05]

Effect of tadalafil on anaerobic performance indices in healthy athletes. [2008.02]

Inhibition of phosphodiesterase type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with cardiovascular risk factors and erectile dysfunction. [2008.01]

Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study. [2008]

Tadalafil (Cialis) and erectile dysfunction after radiotherapy for prostate cancer: an open-label extension of a blinded trial. [2007.12]

more>>

Clinical Trials Related to Cialis (Tadalafil)

Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying [Completed]

Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia [Active, not recruiting]

PHIRST-1: Tadalafil in the Treatment of Pulmonary Arterial Hypertension [Completed]

Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection [Completed]

A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction [Completed]

more>>

Page last updated: 2008-08-28

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008